Review of the therapeutic management of Parkinson's disease. Report of a joint task force of the European Federation of Neurological Societies (EFNS) and the Movement Disorder Society-European Section (MDS-ES). Part II: late (complicated) Parkinson's disease

被引:141
作者
Horstink, M.
Tolosa, E.
Bonuccelli, U.
Deuschl, G.
Friedman, A.
Kanovsky, P.
Larsen, J. P.
Lees, A.
Oertel, W.
Poewe, W.
Rascol, O.
Sampaio, C.
机构
[1] Radboud Univ Nijmegen, Dept Neurol, Med Ctr, NL-6500 HB Nijmegen, Netherlands
[2] Univ Barcelona, Neurol Serv, Hosp Clin, Barcelona, Spain
[3] Univ Pisa, Dept Neurosci, Pisa, Italy
[4] Univ Kiel, Dept Neurol, D-2300 Kiel, Germany
[5] Med Univ Warsaw, Dept Neurol, Warsaw, Poland
[6] Palacky Univ, Dept Neurol, CR-77147 Olomouc, Czech Republic
[7] Reta Lila Weston Inst Neurol Studies, London, England
[8] Univ Marburg, Ctr Nervous Dis, Marburg, Germany
[9] Innsbruck Med Univ, Dept Neurol, Innsbruck, Austria
[10] Univ Hosp, Clin Invest Ctr, Dept Clin Pharmacol, Toulouse, France
[11] Univ Hosp, Dept Neurosci, Toulouse, France
[12] Fac Med Lisbon, Lab Farmacol Clin & Terapeut, Lisbon, Portugal
[13] Fac Med Lisbon, Inst Mol Med, Lisbon, Portugal
关键词
management guideline; neurosurgery; Parkinson's disease; pharmacotherapy; review;
D O I
10.1111/j.1468-1331.2006.01548.x
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
To provide evidence-based recommendations for the management of late (complicated) Parkinson's disease (PD), based on a review of the literature. Complicated PD refers to patients suffering from the classical motor syndrome of PD along with other motor or non-motor complications, either disease-related (e.g. freezing) or treatment-related (e.g. dyskinesias or hallucinations). MEDLINE, Cochrane Library and INAHTA database literature searches were conducted. National guidelines were requested from all EFNS societies. Non-European guidelines were searched for using MEDLINE. Part II of the guidelines deals with treatment of motor and neuropsychiatric complications and autonomic disturbances. For each topic, a list of therapeutic interventions is provided, including classification of evidence. Following this, recommendations for management are given, alongside ratings of efficacy. Classifications of evidence and ratings of efficacy are made according to EFNS guidance. In cases where there is insufficient scientific evidence, a consensus statement ('good practice point') is made.
引用
收藏
页码:1186 / 1202
页数:17
相关论文
共 206 条
[1]   Cognitive, psychiatric and motor response to galantamine in Parkinson's disease with dementia [J].
Aarsland, D ;
Hutchinson, M ;
Larsen, JP .
INTERNATIONAL JOURNAL OF GERIATRIC PSYCHIATRY, 2003, 18 (10) :937-941
[2]   Prevalence and characteristics of dementia in Parkinson disease - An 8-year prospective study [J].
Aarsland, D ;
Andersen, K ;
Larsen, JP ;
Lolk, A ;
Kragh-Sorensen, P .
ARCHIVES OF NEUROLOGY, 2003, 60 (03) :387-392
[3]   Donepezil for cognitive impairment in Parkinson's disease: a randomised controlled study [J].
Aarsland, D ;
Laake, K ;
Larsen, JP ;
Janvin, C .
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 2002, 72 (06) :708-712
[4]   Frequency of dementia in Parkinson disease [J].
Aarsland, D ;
Tandberg, E ;
Larsen, JP ;
Cummings, JL .
ARCHIVES OF NEUROLOGY, 1996, 53 (06) :538-542
[5]   Randomized, placebo-controlled study of tolcapone in patients with fluctuating Parkinson disease treated with levodopa-carbidopa [J].
Adler, CH ;
Singer, C ;
O'Brien, C ;
Hauser, RA ;
Lew, MF ;
Marek, KL ;
Dorflinger, E ;
Pedder, S ;
Deptula, D ;
Yoo, K .
ARCHIVES OF NEUROLOGY, 1998, 55 (08) :1089-1095
[6]   BROMOCRIPTINE ASSOCIATED WITH A PERIPHERAL DOPAMINE BLOCKING-AGENT IN TREATMENT OF PARKINSONS-DISEASE [J].
AGID, Y ;
BONNET, AM ;
POLLAK, P ;
SIGNORET, JL ;
LHERMITTE, F .
LANCET, 1979, 1 (8116) :570-572
[7]   PARKINSONS-DISEASE AND DEMENTIA [J].
AGID, Y ;
RUBERG, M ;
DUBOIS, B ;
PILLON, B ;
CUSIMANO, G ;
RAISMAN, R ;
CASH, R ;
LHERMITTE, F ;
JAVOYAGID, F .
CLINICAL NEUROPHARMACOLOGY, 1986, 9 :S22-S36
[8]  
Agid Y, 1999, MOVEMENT DISORD, V14, P38
[9]   Tolcapone, bromocriptine, and Parkinson's disease [J].
Agid, Y ;
Destee, A ;
Durif, F ;
Montastruc, JL ;
Pollak, P .
LANCET, 1997, 350 (9079) :712-713
[10]   CONTROLLED-RELEASE SINEMET (CR-4) - A DOUBLE-BLIND CROSSOVER STUDY IN PATIENTS WITH FLUCTUATING PARKINSONS-DISEASE [J].
AHLSKOG, JE ;
MUENTER, MD ;
MCMANIS, PG ;
BELL, GN ;
BAILEY, PA .
MAYO CLINIC PROCEEDINGS, 1988, 63 (09) :876-886